E
Telomir Pharmaceuticals, Inc. TELO
$4.58 -$0.45-8.95%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 68.93% -246.56% 6.54% -1,195.22% -1,814.84%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -100.00% -100.00% -100.00% -- --
Total Other Non-Cash Items -70.67% 35,759.70% -- -- --
Change in Net Operating Assets 336.96% 111.73% -105.30% 90.74% -90.06%
Cash from Operations 44.28% 49.96% -4,432.14% -163.61% -325.02%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -108.48% -72.86% -- 338.49%
Total Debt Repaid -100.00% -233.77% -- -- --
Issuance of Common Stock 1,052.56% -- -- 483.30% 63.64%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -7.20% 100.00% -96.85% -323.68%
Cash from Financing -4.48% -102.36% 185.34% 608.12% 332.84%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 36,058.33% -8,500.82% -10,962.50% 818,175.00% 75.51%
Weiss Ratings